Hikma Pharmaceuticals PLC announced the following changes to its board of directors and their responsibilities: Dr. Pamela Kirby has decided not to stand for re-election at the next annual general meeting of the Company that is scheduled to take place on 25 April 2022; and Nina Henderson will take over as chair of the Remuneration Committee with effect from the end of the annual general meeting.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2,005 GBX | -0.25% | +1.77% | +12.24% |
Jun. 11 | Citigroup Hikes Hikma Pharmaceuticals PT, Maintains Buy Rating | MT |
Jun. 11 | Morgan Stanley cuts Anglo American | AN |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.24% | 5.73B | |
+48.79% | 781B | |
+41.63% | 639B | |
+19.43% | 330B | |
+7.18% | 293B | |
+17.79% | 248B | |
-0.33% | 221B | |
+11.79% | 217B | |
+4.53% | 162B | |
-3.92% | 157B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Hikma Pharmaceuticals Announces Directorate Change